1. Home
  2. BDC vs IDYA Comparison

BDC vs IDYA Comparison

Compare BDC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$112.65

Market Cap

4.4B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$36.84

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDC
IDYA
Founded
1902
2015
Country
United States
United States
Employees
8000
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
BDC
IDYA
Price
$112.65
$36.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
16
Target Price
★ $162.50
$52.86
AVG Volume (30 Days)
390.0K
★ 661.4K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
★ 0.16%
N/A
EPS Growth
23.13
★ 61.90
EPS
★ 3.04
N/A
Revenue
★ $2,715,194,000.00
$218,710,000.00
Revenue This Year
$8.91
N/A
Revenue Next Year
$4.70
$201.05
P/E Ratio
$36.45
★ N/A
Revenue Growth
10.33
★ 3024.43
52 Week Low
$98.00
$26.05
52 Week High
$159.99
$42.68

Technical Indicators

Market Signals
Indicator
BDC
IDYA
Relative Strength Index (RSI) 45.18 41.90
Support Level $109.03 $34.74
Resistance Level $122.09 $38.37
Average True Range (ATR) 3.61 1.28
MACD -0.25 -0.28
Stochastic Oscillator 18.14 29.25

Price Performance

Historical Comparison
BDC
IDYA

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: